Paper40132017
Preclinical Profile of CM699 as a Medication Candidate for Stimulant Use Disorder.
Hiranita T and 12 others. ACS Chem Neurosci, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Preclinical Profile of CM699 as a Medication Candidate for Stimulant Use Disorder. Papers, record 40132017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40132017
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptors, sigma | Major topic |
| Central Nervous System Stimulants | Major topic |
| Substance-Related Disorders | Major topic |
| Animals | |
| Male | |
| Dopamine Plasma Membrane Transport Proteins | |
| Rats | |
| Rats, Sprague-Dawley | |
| Self Administration | |
| Dopamine | |
| Cocaine | |
| Dopamine Uptake Inhibitors | |
| Nucleus Accumbens |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DA058018 | NIDA NIH HHS | United States | R01DA058018 | PubMed and NIH | NIH RePORTER |
| Z01 DA000103 | Intramural NIH HHS | United States | Z01DA000103 | PubMed | NIH RePORTER |
| R01 DA023205 | NIDA NIH HHS | United States | R01DA023205 | PubMed and NIH | NIH RePORTER |
| ZIA DA000103 | Intramural NIH HHS | United States | ZIADA000103 | PubMed | NIH RePORTER |
| ZIA DA000611 | Intramural NIH HHS | United States | ZIADA000611 | PubMed and NIH | NIH RePORTER |
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37311803 | Interactions of calmodulin kinase II with the dopamine transporter facilitate cocaine-induced enhancement of evoked dopamine release. | Transl Psychiatry | 2023 | https://conductscience.org/library/papers/37311803 | PubMed |
| 2 | 21859929 | Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors. | J Pharmacol Exp Ther | 2011 | https://conductscience.org/library/papers/21859929 | PubMed |
| 3 | 15681658 | Effects of 4'-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine. | J Pharmacol Exp Ther | 2005 | https://conductscience.org/library/papers/15681658 | PubMed |
| 4 | 25970245 | Neurotransmitter and psychostimulant recognition by the dopamine transporter. | Nature | 2015 | https://conductscience.org/library/papers/25970245 | PubMed |
| 5 | 8378254 | Physiological parameters in laboratory animals and humans. | Pharm Res | 1993 | https://conductscience.org/library/papers/8378254 | PubMed |
| 6 | 18363822 | Cocaine-like neurochemical effects of antihistaminic medications. | J Neurochem | 2008 | https://conductscience.org/library/papers/18363822 | PubMed |
| 7 | 28495886 | The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats. | J Biol Chem | 2017 | https://conductscience.org/library/papers/28495886 | PubMed |
| 8 | 1686761 | Selective sigma ligands block stimulant effects of cocaine. | Eur J Pharmacol | 1991 | https://conductscience.org/library/papers/1686761 | PubMed |
| 9 | 12490613 | Sigma1 receptor agonist-mediated regulation of N-methyl-D-aspartate-stimulated [3H]dopamine release is dependent upon protein kinase C. | J Pharmacol Exp Ther | 2003 | https://conductscience.org/library/papers/12490613 | PubMed |
| 10 | 23187725 | Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists. | Neuropsychopharmacology | 2013 | https://conductscience.org/library/papers/23187725 | PubMed |
| 11 | 8726752 | Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. | Neuropsychopharmacology | 1996 | https://conductscience.org/library/papers/8726752 | PubMed |
| 12 | 24518035 | 2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter. | J Pharmacol Exp Ther | 2014 | https://conductscience.org/library/papers/24518035 | PubMed |
| 13 | 28110353 | A Role for Sigma Receptors in Stimulant Self-Administration and Addiction. | Handb Exp Pharmacol | 2017 | https://conductscience.org/library/papers/28110353 | PubMed |
| 14 | 20688912 | Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20688912 | PubMed |
| 15 | 20950794 | Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. | Biol Psychiatry | 2011 | https://conductscience.org/library/papers/20950794 | PubMed |
| 16 | 7783132 | Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines. | J Med Chem | 1995 | https://conductscience.org/library/papers/7783132 | PubMed |
| 17 | 22112179 | Targeting sigma receptors: novel medication development for drug abuse and addiction. | Expert Rev Clin Pharmacol | 2009 | https://conductscience.org/library/papers/22112179 | PubMed |
| 18 | 29945932 | Dopamine Transporter Dynamics of N-Substituted Benztropine Analogs with Atypical Behavioral Effects. | J Pharmacol Exp Ther | 2018 | https://conductscience.org/library/papers/29945932 | PubMed |
| 19 | 8276070 | Cocaine and several sigma receptor ligands inhibit dopamine uptake in rat caudate-putamen. | Eur J Pharmacol | 1993 | https://conductscience.org/library/papers/8276070 | PubMed |
| 20 | 17268407 | Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward. | Neuropsychopharmacology | 2007 | https://conductscience.org/library/papers/17268407 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41092850 | Dual sigma receptor/dopamine transporter inhibition and the union of pharmacology and experimental psychology. | J Pharmacol Exp Ther | 2025 | https://conductscience.org/library/papers/41092850 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40132017
GET https://conductscience.org/api/papers/v1/40132017/references?page=2